Cleared Traditional

coactiv+? Antimicrobial Wound Gel

K223259 · Kane Biotech, Inc. · General & Plastic Surgery
May 2023
Decision
212d
Days
Risk

About This 510(k) Submission

K223259 is an FDA 510(k) clearance for the coactiv+? Antimicrobial Wound Gel, a Dressing, Wound, Drug, submitted by Kane Biotech, Inc. (Winnipeg, CA). The FDA issued a Cleared decision on May 24, 2023, 212 days after receiving the submission on October 24, 2022. This device falls under the General & Plastic Surgery review panel.

Submission Details

510(k) Number K223259 FDA.gov
FDA Decision Cleared SESE
Date Received October 24, 2022
Decision Date May 24, 2023
Days to Decision 212 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FRO — Dressing, Wound, Drug
Device Class

Similar Devices — FRO Dressing, Wound, Drug

All 698
Promogran Prisma? Collagen Matrix with ORC and Silver
K251999 · Solventum Germany GmbH · Mar 2026
LUOFUCON? Antimicrobial Wound Gel
K252028 · Huizhou Foryou Medical Co., Ltd. · Mar 2026
Redermax Antibacterial Wound Matrix
K251582 · Beijing Kreate Medical Co., Ltd. · Feb 2026
New Day Skin Spray
K252568 · Silk Holdings, Inc. · Jan 2026
SBC1 Cream
K250890 · Sioxmed, LLC · Jan 2026
revyve? Antimicrobial Skin and Wound Cleanser
K252759 · Kane Biotech, Inc. · Jan 2026